1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Orion Nutraceuticals Inc.

Orion Nutraceuticals Inc.

ORI.CN
Orion Nutraceuticals Inc.CA flagCanadian Securities Exchange
0.40
CAD
- -
- -
11.72MMarket Cap
Orion Nutraceuticals Inc.
ORI.CN
(Canadian Securities Exchange)

Recent

price

0.40

P/E

ratio

- -

div

yld

- -

ROIC.AI

2018
2019
2020
2021
2022
2023
2024
TTM
FRC
- -
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
- -
-3.67
-0.2
-0.03
-0.09
-0.01
- -
-0.02
Basic EPS, GAAP
- -
-1.04
-0.03
-0.04
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
-0.71
-0.53
0.02
-0.07
-0.08
-0.08
-0.08
Book Value per Share
- -
-0.22
-0.14
0.07
-0.02
-0.03
-0.03
-0.04
Tangible Book Value per Share
- -
2
2
27
29
29
29
29
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
-6
- -
-1
-3
- -
- -
-1
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
2
-1
-1
-1
-1
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
1
- -
- -
2
-1
-1
-1
-1
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
May'24
Aug'25
Nov'25
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
29
29
29
Market Capitalization
- -
- -
- -

Working Capital

FRC

•

in mil. unless spec.
May'24
Aug'25
Nov'25
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
1
1
1
Payables & Accruals
1
1
1
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-191.94%
6.76%
Free Cash Flow
- -
326.55%
9.97%
Net Income, GAAP
- -
12.94%
-77.9%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
-0.01
- -
-0.01
2024
-0.01
0.01
- -
- -
- -
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Similar Companies
Changzhou Qianhong Biopharma CO.,LTD (002550.SZ)
Lotus Ventures Inc. (LTTSF)
Levitee Labs Inc. (LVT.CN)
Trulieve Cannabis Corp. (TCNNF)
HempAmericana, Inc (HMPQ)
Canada House Cannabis Group Inc. (CHV.CN)
Business
Orion Nutraceuticals Inc. is actively evaluating prospective investment and acquisition opportunities across various sectors. The company, which originated in 2017 and is headquartered in Vancouver, Canada, is slated to undergo a corporate name change to Pinetown Ventures Corp. and implement a share consolidation, both effective September 9, 2025. It previously focused on the cannabis life science industry and medicinal cannabis initiatives in Colombia.